ARMISTICE CAPITAL, LLC Portfolio Holdings
Q3 2025•313 long positions•$3.2B portfolio value
We use cookies for analytics. See our Privacy and Cookie Policy.
Choose which columns to filter the table by
Choose which columns to display in the table
Holding376 | Sector | Position↕ | Traded↕ | Ownership↕ | Shares Δ↕ | Shares Δ % | Market Cap↕ | Owned Since↕ |
|---|---|---|---|---|---|---|---|---|
Biotechnology Healthcare | $201.1M 6.38% | -$89.5M Sold | 4.13% 3.3M shares | 4.7M → 3.3M −$89.5M | -30.79% | $4.9B Mid Cap | Q4 2018 Held for 6y 11m | |
Biotechnology Healthcare | $160.7M 5.1% | -$51.4M Sold | 7.54% 6.7M shares | 8.9M → 6.7M −$51.4M | -24.25% | $2.1B Mid Cap | Q1 2021 Held for 4y 8m | |
Drug Manufacturers - Specialty & Generic Healthcare | $135.5M 4.3% | -$94.4M Sold | 5.06% 2.8M shares | 4.8M → 2.8M −$94.4M | -41.06% | $2.7B Mid Cap | Q4 2019 Held for 5y 11m | |
Biotechnology Healthcare | $99.0M 3.14% | -$14.3M Sold | 0.598% 1.2M shares | 1.3M → 1.2M −$14.3M | -12.62% | $16.6B Large Cap | Q2 2018 Held for 7y 5m | |
Drug Manufacturers - Specialty & Generic Healthcare | $97.8M 3.11% | +$2.9M Bought | 0.703% 697.0K shares | 676.0K → 697.0K +$2.9M | +3.11% | $13.9B Large Cap | Q1 2022 Held for 3y 8m | |
Biotechnology Healthcare | $94.1M 2.99% | +$10.3M Bought | 3.35% 5.8M shares | 5.2M → 5.8M +$10.3M | +12.23% | $2.8B Mid Cap | Q3 2023 Held for 2y 2m | |
Medical - Instruments & Supplies Healthcare | $72.8M 2.31% | +$66.4M Bought | 2.88% 5.7M shares | 501.4K → 5.7M +$66.4M | +1,043.97% | $2.5B Mid Cap | Q4 2022 Held for 2y 11m | |
Biotechnology Healthcare | $70.4M 2.23% | +$14.2M Bought | 0.118% 125.2K shares | 100.0K → 125.2K +$14.2M | +25.17% | $59.6B Large Cap | Q1 2017 Held for 8y 8m | |
Packaged Foods Consumer Defensive | $68.0M 2.16% | +$36.9M Bought | 2.53% 1.2M shares | 565.4K → 1.2M +$36.9M | +118.39% | $2.7B Mid Cap | Q1 2022 Held for 3y 8m | |
Specialty Retail Consumer Cyclical | $67.9M 2.16% | +$19.8M Bought | 0.003% 309.4K shares | 219.4K → 309.4K +$19.8M | +41.01% | $2.34T Mega Cap | Q2 2022 Held for 3y 5m | |
Biotechnology Healthcare | $65.8M 2.09% | -$6.3M Sold | 1.0% 1.2M shares | 1.3M → 1.2M −$6.3M | -8.8% | $6.6B Mid Cap | Q1 2024 Held for 1y 8m | |
Medical - Healthcare Information Services Healthcare | $59.7M 1.9% | +$2.9M Bought | 0.174% 795.1K shares | 756.3K → 795.1K +$2.9M | +5.13% | $34.3B Large Cap | Q3 2024 Held for 1y 2m | |
Medical - Diagnostics & Research Healthcare | $56.4M 1.79% | +$15.8M Bought | 0.544% 1.0M shares | 742.0K → 1.0M +$15.8M | +38.88% | $10.4B Large Cap | Q3 2022 Held for 3y 2m | |
Internet Content & Information Communication Services | $56.1M 1.78% | +$9.8M Bought | 0.002% 230.7K shares | 190.4K → 230.7K +$9.8M | +21.16% | $2.95T Mega Cap | Q3 2021 Held for 4y 2m | |
Biotechnology Healthcare | $55.0M 1.75% | -$1.8M Sold | 0.538% 120.0K shares | 124.0K → 120.0K −$1.8M | -3.24% | $10.2B Large Cap | Q2 2016 Held for 9y 5m | |
Software - Infrastructure Technology | $48.4M 1.54% | +$4.0M Bought | 2.59% 2.0M shares | 1.8M → 2.0M +$4.0M | +8.93% | $1.9B Small Cap | Q1 2023 Held for 2y 8m | |
Software - Infrastructure Technology | $45.2M 1.43% | +$1.8M Bought | 0.001% 87.2K shares | 83.7K → 87.2K +$1.8M | +4.19% | $3.85T Mega Cap | Q3 2020 Held for 5y 2m | |
Unknown Unknown | $42.8M 1.36% | -$16.2M Sold | — 58.0K shares | 80.0K → 58.0K −$16.2M | -27.5% | — — | Q1 2025 Held for 8 months | |
Medical - Devices Healthcare | $42.4M 1.35% | +$375.8K Bought | 10.0% 6.3M shares | 6.3M → 6.3M +$375.8K | +0.89% | $423.9M Small Cap | Q4 2023 Held for 1y 11m | |
Biotechnology Healthcare | $41.3M 1.31% | -$13.5M Sold | 5.38% 4.7M shares | 6.2M → 4.7M −$13.5M | -24.65% | $768.2M Small Cap | Q4 2022 Held for 2y 11m | |
Unknown Unknown | $40.8M 1.3% | +$40.8M Bought | — 736.0K shares | — | — | — — | Q2 2024 Held for 1y 5m | |
Gambling, Resorts & Casinos Consumer Cyclical | $40.5M 1.29% | +$13.3M Bought | 1.44% 2.1M shares | 1.4M → 2.1M +$13.3M | +48.82% | $2.8B Mid Cap | Q4 2023 Held for 1y 11m | |
Biotechnology Healthcare | $38.8M 1.23% | +$6.4M Bought | 2.15% 3.1M shares | 2.6M → 3.1M +$6.4M | +19.69% | $1.8B Small Cap | Q2 2023 Held for 2y 5m | |
Software - Infrastructure Technology | $34.9M 1.11% | +$2.8M Bought | 0.138% 112.4K shares | 103.5K → 112.4K +$2.8M | +8.6% | $25.3B Large Cap | Q1 2025 Held for 8 months | |
Medical - Devices Healthcare | $32.7M 1.04% | -$10.9M Sold | 5.66% 2.2M shares | 3.0M → 2.2M −$10.9M | -24.92% | $578.2M Small Cap | Q4 2022 Held for 2y 11m | |
Biotechnology Healthcare | $30.7M 0.973% | -$16.2M Sold | 1.31% 764.0K shares | 1.2M → 764.0K −$16.2M | -34.59% | $2.3B Mid Cap | Q3 2022 Held for 3y 2m | |
Restaurants Consumer Cyclical | $30.1M 0.956% | +$30.1M Bought | 0.031% 356.1K shares | — | — | $96.2B Large Cap | Q3 2025 Held for 2 months | |
Unknown Unknown | $29.9M 0.95% | +$5.3M Bought | — 824.0K shares | 678.0K → 824.0K +$5.3M | +21.53% | — — | Q1 2025 Held for 8 months | |
Drug Manufacturers - General Healthcare | $29.3M 0.93% | +$29.3M Bought | 0.032% 649.7K shares | — | — | $91.8B Large Cap | Q3 2025 Held for 2 months | |
Medical - Devices Healthcare | $28.9M 0.917% | +$5.4M Bought | 5.39% 2.5M shares | 2.0M → 2.5M +$5.4M | +22.79% | $536.4M Small Cap | Q1 2025 Held for 8 months | |
Unknown Unknown | $28.9M 0.917% | +$28.9M Bought | — 612.0K shares | — | — | — — | Q3 2024 Held for 1y 2m | |
Biotechnology Healthcare | $28.8M 0.914% | — | 1.25% 436.0K shares | — | — | $2.3B Mid Cap | Q3 2024 Held for 1y 2m | |
Software - Application Technology | $28.8M 0.913% | +$7.4M Bought | 0.058% 202.1K shares | 150.0K → 202.1K +$7.4M | +34.71% | $49.7B Large Cap | Q4 2021 Held for 3y 11m | |
Unknown Unknown | $27.9M 0.885% | +$17.5M Bought | — 156.0K shares | 58.0K → 156.0K +$17.5M | +168.97% | — — | Q4 2024 Held for 11 months | |
Medical - Diagnostics & Research Healthcare | $26.7M 0.847% | +$12.2M Bought | 0.015% 55.0K shares | 30.0K → 55.0K +$12.2M | +83.61% | $183.15B Large Cap | Q1 2020 Held for 5y 8m | |
Medical - Devices Healthcare | $25.3M 0.802% | +$119.7K Bought | 0.021% 265.3K shares | 264.0K → 265.3K +$119.7K | +0.48% | $122.16B Large Cap | Q2 2020 Held for 5y 5m | |
Unknown Unknown | $23.9M 0.76% | +$10.0M Bought | 0.085% 213.3K shares | 124.0K → 213.3K +$10.0M | +72.0% | $28.0B Large Cap | Q4 2024 Held for 11 months | |
Unknown Unknown | $23.0M 0.732% | +$23.0M New | — 3.0M shares | 0 → 3.0M +$23.0M | New | — — | Q3 2025 Held for 2 months | |
Unknown Unknown | $22.3M 0.707% | -$50.4M Sold | — 2.2M shares | 7.3M → 2.2M −$50.4M | -69.36% | — — | Q1 2024 Held for 1y 8m | |
Medical - Healthcare Plans Healthcare | $22.0M 0.698% | +$22.0M Bought | 0.023% 291.8K shares | — | — | $95.6B Large Cap | Q3 2025 Held for 2 months | |
Medical - Devices Healthcare | $21.4M 0.679% | +$1.6M Bought | 2.61% 1.2M shares | 1.1M → 1.2M +$1.6M | +7.98% | $820.9M Small Cap | Q3 2024 Held for 1y 2m | |
Drug Manufacturers - Specialty & Generic Healthcare | $21.2M 0.671% | — | 9.94% 16.2M shares | — | — | $212.8M Micro Cap | Q3 2023 Held for 2y 2m | |
Software - Application Technology | $21.1M 0.668% | +$10.7M Bought | 0.085% 45.0K shares | 22.1K → 45.0K +$10.7M | +103.66% | $24.6B Large Cap | Q4 2023 Held for 1y 11m | |
Biotechnology Healthcare | $20.5M 0.651% | -$24.8M Sold | 4.04% 724.0K shares | 1.6M → 724.0K −$24.8M | -54.75% | $508.2M Small Cap | Q3 2022 Held for 3y 2m | |
Biotechnology Healthcare | $19.6M 0.623% | -$2.8M Sold | 7.57% 4.2M shares | 4.8M → 4.2M −$2.8M | -12.5% | $259.0M Micro Cap | Q2 2018 Held for 7y 5m | |
Software - Infrastructure Technology | $19.6M 0.621% | -$2.2M Sold | — 1.1M shares | 1.2M → 1.1M −$2.2M | -10.06% | — — | Q3 2022 Held for 3y 2m | |
Software - Application Technology | $19.4M 0.615% | +$8.5M Bought | 0.133% 400.0K shares | 224.0K → 400.0K +$8.5M | +78.58% | $14.6B Large Cap | Q1 2025 Held for 8 months | |
Biotechnology Healthcare | $19.3M 0.611% | +$12.5M Bought | 0.654% 507.7K shares | 178.0K → 507.7K +$12.5M | +185.2% | $2.9B Mid Cap | Q2 2025 Held for 5 months | |
Biotechnology Healthcare | $18.5M 0.587% | -$353.2K Sold | 3.41% 2.1M shares | 2.1M → 2.1M −$353.2K | -1.87% | $543.4M Small Cap | Q2 2025 Held for 5 months | |
Specialty Retail Consumer Cyclical | $18.4M 0.585% | +$13.9M Bought | 0.484% 90.7K shares | 22.3K → 90.7K +$13.9M | +306.81% | $3.8B Mid Cap | Q4 2024 Held for 11 months |
